胺碘酮治疗房颤和室性心动过速的临床疗效对比观察

TheClinic Observation Of Amiodarone Treatments Between Atrial Fibrillation(AF)and Ventricular Tachycardia(VT)

目的:评价胺碘酮治疗房颤和室性心动过速的临床疗效对比观察。方法:2015年12月到2016年12月间我院收治的胺碘酮治疗的17例房颤和17例室性心动过速患者,分别应用胺碘酮治疗后的临床疗效的比较分析。结果:房颤组患者应用胺碘酮治疗的有效率为47.06%,而室速组应用胺碘酮治疗的有效率为88.24%,胺碘酮治疗室性心动过速患者的疗效优于房颤患者(P<0.05)。结论:在无胺碘酮应用禁忌症的房颤和室速患者中,胺碘酮是一种较安全和有效的药物,值得临床推广应用,对于室性心动过速的患者其疗效更明显。

Objective:To evaluate the effects and make comparison the between amiodarone treatments for AF and VT.Methods:We selected the patients from December 2015 to December 2016,concluding 17 atrial fibrillation(AF)ones and 17 ventricular tachycardia(VF)ones.using amiodarone therapied these patients and evaluated the curative effect.Result:The average age of AF Group was 60.47±16.03(25-84)year old,while the VF group’s was 42.76±21.19(17-83)year old,the clinical materials of two groups of patients had no significant difference(P>0.05).The effective rate of Application of amiodarone therapy in patients with AF was 47.06%,and the one of VT group applied amiodarone treatment was 88.24%,the curative effect of amiodarone treatment in VT is better than that of patients with AF(P<0.05).Conclusion:Amiodarone is a relatively safe and effective drug used in patients with atrial fibrillation and ventricular tachycardia with no application of amiodarone contraindication,it should be applied widely in clinical treatment of arrhythmia,and it has more obvious effection in patients with ventricular tachycardia.